Custom Search

Tuesday, March 27, 2012

Music Therapy

Music, an abstract stimulus, can arouse feelings of euphoria, similar to tangible rewards that involve the striatal dopaminergic system. Using the neurochemical specificity of positron emission tomography scanning, combined with psychophysiological measures of autonomic nervous system activity, scientists found endogenous dopamine release in the striatum at peak emotional arousal during music listening. To examine the time course of dopamine release, they used functional magnetic resonance imaging with the same stimuli and listeners, and found a functional dissociation: the caudate was more involved during the anticipation and the nucleus accumbens was more involved during the experience of peak emotional responses to music. These results indicate that intense pleasure in response to music can lead to dopamine release in the striatal system. Notably, the anticipation of an abstract reward can result in dopamine release in an anatomical pathway distinct from that associated with the peak pleasure itself. Their results help to explain why music is of such high value across all human societies.


This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Wednesday, March 21, 2012

Statement from Reckitt Benckiser concerning Subutex

“Reckitt Benckiser Pharmaceuticals Inc. is discontinuing distribution and sale of Subutex® tablets as we believe that mono product (product containing buprenorphine alone with no naloxone) creates a greater risk of misuse, abuse and diversion, and while other mono product may be available on the market, we are concentrating our efforts around less abusable products in order to protect patients, communities and access to treatment.”


This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Wednesday, March 7, 2012

Oxycontin Banned in Canada

Addiction experts are applauding Ontario’s new restrictions on OxyContin and the drug replacing it, but say the country needs a national strategy to tackle widespread abuse of prescription painkillers.
The province’s decision to remove OxyContin and its successor from the list of drugs it routinely funds is a “very positive thing overall,” said Dr. Irfan Dhalla of Toronto’s St. Michael’s Hospital.
His research found the addition of long-acting oxycodone — the form contained in OxyContin — to Ontario’s drug plan in 2000 coincided with a spike in opioid-related deaths.
Imposing tighter controls on prescriptions “is not going to solve the problem by itself, but it’s a major step forward,” he said.
The maker of OxyContin will stop manufacturing the drug in Canada at the end of the month and replace it with a new formulation called OxyNeo.
Ontario health officials said Friday the new drug will be funded through the province’s Exceptional Access Program, meaning prescriptions will fall under stricter regulations.
As other provinces weigh whether to include OxyNeo in their formulary, experts such as Dhalla are urging Ottawa to take the lead in combating what has become a national health crisis.
Benedikt Fischer, director of the Centre for Applied Research in Addictions and Mental Health at Simon Fraser University, said “concerted measures” could help prevent smuggling of the drug across provincial borders.
“Let’s say in Manitoba or in Quebec, the restrictions aren’t there, there’s a much higher supply and there’s a great black market demand in Ontario, it’s quite possible the stuff will come in from the neighbouring provinces,” he said.
“It’s one reason why approaches to those kinds of measures in Canada should really be harmonized across the board,” he said.
Manitoba and British Columbia are among a handful of provinces that have yet to decide whether to fund OxyNeo once OxyContin is discontinued.
Prince Edward Island and New Brunswick have chosen not to pay for the new drug, which is formulated to make abuse more difficult.
Unlike OxyContin the tablet is hard to crush and when added to liquid it forms a thick gel that stops oxycodone from being extracted for injection.
But that won’t help those who have developed addictions to the drug in pill form, Fischer said. “They can still simply swallow it,” he said.


This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.